Currently, Wockhardt has made available 6 generic drug products for the US customers (scroll down for the list). In addition we have over 15 applications under FDA review and 60 projects in various stages of the developmental pipeline and these would be available to the US customers in future. Wockhardt continues to invest in research and development and is committed to provide its US customers quality drug products at the right time and at competitive prices.

Sr.
Product
Dosage form
Strength
TE code
Prescription information
1
Bethanechol chloride
Tablet, Oral
5, 10, 25 and
50 mg.
AB
2
Captopril
Tablet, Oral
12.5, 25, 50 and 100 mg
AB
3
Cefuroxime Axetil
Tablet, Oral
125, 250 and
500 mg
AB
4
Enalapril maleate
Tablet, Oral
2.5, 5, 10 and
20 mg
AB
5
Famotidine
Tablet, Oral
20 and 40 mg
AB
6
Ranitidine hydrochloride
Tablet, Oral
EQ. 150 and 300 mg base
AB

 
Wockhardt is emerging as a leading manufacturer of several APIs. Thanks to Wockhardt’s ten strategically located world class manufacturing facilities in India and UK. Wockhardt’s plants, including Sterile, API and Formulations, are approved by various international regulatory authorities such as US FDA, UK MHRA, and Australian TGA. Currently, Wockhardt has filed DMF for the following API products.
Azithromycin (anhydrous and Form I)
D-oxyphene base
Bethanechol chloride
Enalapril maleate
Captopril
Felodipine
Cefotaxime sodium
Fexofenadine hydrochloride
Ceftazidime
Fluconazole
Ceftriaxone sodium (sterile)
Fluoxetine hydrochloride
Cefuroxime axetil (amorphous)
Metformin hydrochloride
Cefuroxime sodium (sterile)
Niacin
Ciprofloxacin hydrochloride
Nizatidine
Citalopram hydrobromide
Omeprazole
Clarithromycin
Oxybutynin chloride
Dextromethorphan hydrobromide
Ranitidine hydrochloride
Dextropropoxyphene napsylate
Sterile sodium carbonate
Divalproex sodium
Zonisamide
 
  2005, Wockhardt USA, All Rights Reserved
Legal Disclaimer    |    Terms of Use    |    Privacy Policy